New Delhi: Vitamin C – which is an important part of most recipes for Covid-19 patients – does not have significant benefits in the treatment of infectious diseases, the results of the systemic review and meta-analysis of randomized controlled trials from all Delhi of the epidemiology of the Indian Medical Sciences Institute (AIIMS) shows.
“Vitamin C therapy does not reduce the main health results in Covid patients.
In sub-group analysis based on drug doses (high levels of low), route (iv vs.
oral) and disease severity (severe vs non-severe) there are no significant benefits observed, “this research was concluded.
The research writers recommend a greater prospective randomized trial to evaluate the influence of isolated vitamin C administration, separately for full and draining vitamin C individuals.
This research was published online at Elevier Diabetes & Metabolic Syndrome: Research & Clinical Reviews.
Doctors say these findings have significance because vitamin C supplementation increases significantly with people even with the assumption that this can even prevent infection contracts, which are truly misunderstanding.
“Benefits of vitamin C Since Linus Pauling’s Days are full of uncertainty.
Even though this meta-analysis is categorized as it is without benefit in Covid-19, it is impossible to get a doctor’s recipe sheet in major,” said Dr.
Anoop Misra, Chair, Fortis C-DOC.
Vitamin C, also known as ascorbic acid, is famous for its anti-inflammatory and free radical scavengers.
“Ascorbic acid (vitamin C) has a role in reducing inflammation, vascular injury and disease where oxidative stress increases.
With the same expectations and reasons behind, it is used in high doses in patients who are at high risk of contracting severe covid or have severe covid.
But it is still unclear whether it helps in preventing severe Covid infection.
It must have been inhabited to avoid Covid contracts, “said Dr.
Akshay Budharaja, Pulmonologist, Aakash Healthcare.
This study shows that findings can be due to optimal doses and universally accepted administrative routes.
“Special concerns with Covid-19 is that ICU treatment is needed for the proportion of patients who are rather high.
There is a lot of evidence that critical pain patients have reduced the levels of plasma vitamin C, which are explained by the increasing depletion of vitamins in their bodies, so a third of the ICU patients might be Having low levels of vitamin C such as patients who lack vitamin C, “said Dr Babina Nanda Kumar, Chief Medical Officer, Jindal Naturecure Institute.
According to Dr.
Kumar, although 0.1 g per day Vitamin C can maintain ordinary plasma levels in healthy people, critical painful patients need a much higher dose (2-3 g / day) to increase plasma vitamin C levels with the usual range.
“Therefore, it seems reasonable to filter plasma vitamin C levels in ICU patients and manage vitamin C to those who have a low level,” Dr.
Kumar said.
‘There are no significant benefits of vitamin C doses in Covid-19 treatment’
